Cancer in women
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Cancer in Women: A Comprehensive Overview
Breast Cancer: Prevalence and Molecular Subtypes
Most Common Cancer in Women
Breast cancer is the most frequent malignancy among women globally, accounting for a significant portion of cancer diagnoses . It is particularly prevalent in developed countries, with 12% of cases occurring in women aged 20-34 years. The disease is highly heterogeneous, with molecular features including the activation of HER2, hormone receptors (estrogen and progesterone), and BRCA mutations .
Molecular Subtypes and Treatment Strategies
Breast cancer is classified into several molecular subtypes based on mRNA gene expression levels: Luminal A, Luminal B, HER2-enriched, and basal-like. Treatment strategies vary according to these subtypes and include endocrine therapy for hormone receptor-positive disease, chemotherapy, anti-HER2 therapy, and immunotherapy . The management of breast cancer is multidisciplinary, involving surgery, radiation therapy, and systemic therapies.
Disparities in Breast Cancer Outcomes
Racial Disparities
Significant disparities exist in breast cancer outcomes between different racial groups. For instance, the 5-year survival rate for white women diagnosed with breast cancer is 80%, compared to only 64% for black women. Factors contributing to this disparity include differences in socioeconomic status, access to healthcare, and biological differences in tumor characteristics.
Global Inequities
Globally, the burden of breast cancer is unevenly distributed, with higher mortality rates in low- and middle-income countries (LMICs) due to inadequate access to early detection and treatment . Sustainable investments in cancer control, from prevention to palliative care, are urgently needed in these regions.
Breast Cancer in Young and Elderly Women
Young Women
Breast cancer in young women (under 40 years) is often more aggressive and diagnosed at later stages due to the lack of routine screening . These patients face unique challenges, including concerns about fertility, pregnancy, and the psychosocial impact of the disease . Despite these challenges, there is no evidence that pregnancy post-treatment is detrimental to survival.
Elderly Women
In elderly women (over 70 years), breast cancer tends to present with larger tumors and more frequent metastases. These patients often have hormone-sensitive tumors and lower-grade cancers but face higher breast cancer-specific mortality rates. Biological changes and sociological factors, such as late diagnosis and under-treatment, contribute to these outcomes.
Global Trends and Future Directions
Rising Incidence and Mortality
The incidence of breast cancer is rising globally, particularly in LMICs, due to changes in risk factor profiles and better cancer detection . Despite advancements in treatment, breast cancer remains the leading cause of cancer-related death among women worldwide.
Need for Research and Innovation
There is a critical need for more age-specific clinical data and treatment options, especially for young women. Future therapeutic concepts aim at individualizing therapy based on tumor biology and early therapy response, with a focus on both treatment de-escalation and escalation.
Conclusion
Breast cancer remains a significant global health challenge, with disparities in outcomes based on race, age, and geographic location. Continued research, equitable access to healthcare, and tailored treatment strategies are essential to improve survival rates and quality of life for all women affected by this disease.
Sources and full results
Most relevant research papers on this topic